Since its discovery in 1957 by Isaacs (7) , there has been enormous interest centered on the potential of interferon as an antiviral chemotherapeutic agent. One approach to the use of this antiviral substance in the therapy of virus infections has been the use of interferon inducers to stimulate interferon production in the host. In experimental situations therapy has generally been most effective when interferon inducers have been administered prophylactically (4, 5, 8, 10) . Although this has been interpreted as failure of interferon to act after establishment of infection, an alternate explanation is that the host develops a state of hyporeactivity due to the infection and, therefore, has a decreasing capacity to produce interferon as the infection progresses. Our studies were undertaken to evaluate the capacity of mice to produce interferon in response to injections of a representative group of interferon inducers at various times during the course of an experimental virus infection.
Encephalomyocarditis (EMC) virus was used in these studies as a model systemic picornavirus infection. The pathogenesis of EMC virus in mice after intraperitoneal injections has been previously documented and is characterized by the development of a viremia which is detectable within 24 hr, persists for 24 to 72 hr, and then is cleared as neutralizing antibody appears in the serum (9 Mass.) and housed under conditions of constant temperature and a 12-hr light cycle, with food and water provided ad libitum. After being received from the breeder, mice were housed as described for at least 1 week to allow them to adjust to the new environment before being used.
Cells. Assays were carried out in a cloned, continuous line of mouse L-cell fibroblasts (L929) originally obtained from the American Type Culture Collection cell repository.
Media. Eagle minimum essential medium (MEM; "Auto-Pow," Flow Laboratories, Rockville, Md.) containing 5% fetal calf serum (Grand Island Biological Co., Grand Island, N.Y.), 100 units/ml of penicillin, and 50 jAg of streptomycin per ml was used to propagate and maintain all tissue cultures.
Synthetic interferon inducers. Tilorone hydrochloride (bis-diethylaminoethyl-fluorenone), which had been prepared by the William S. Merrell Co. (Div. of Richardson-Merrell, Inc., Cincinnati, Ohio) and furnished through the Antiviral Substances Program of the National Institutes of Health (NIH; Bethesda, Md.), was stored as a powder at 4 C until used. Prior to use, it was dissolved in phosphate-buffered saline (PBS) at a concentration permitting an inoculum volume of 0.2 ml/mouse. The Tilorone hydrochloride preparation was administered orally by means of an infant feeding catheter attached to a 1-ml syringe.
Polyinosinic-cytidylic acid (poly I:C) was prepared by P-L Laboratories (Milwaukee, Wis.) and was also provided through the Antiviral Substances Program of NIH It was supplied as a premixed solution at a concentration of 1 mg/ml and stored frozen (-20C) until used.
Viruses. The Herts strain of Newcastle disease virus (NDV) was originally obtained from S. Baron Md.) . Pools of VSV were propagated in primary chicken embryo cell monolayers. The stock preparation of VSV used in these studies had a titer of 2.5 X 108 PFU/ml when assayed in L929 mouse cells.
The strain of EMC virus used in these studies was a large-plaque variant originally obtained from K. K. Takemoto (NIH). Suckling mice were injected by the intracerebral route, and brains were removed at the height of disease. These tissues were homogenized and a 10% suspension in MEM was used as a stock pool with a titer of 5 X 106 PFU/ml in L929 mouse cells.
Rochester mouse virus (RMV) is a strain of a largeplaque mutant of EMC virus which was isolated in mouse embryo fibroblast cell cultures from paralyzed and dying 2-week-old suckling mice through which the virus had been blind passaged. This virus was identified as belonging to the EMC group of murine picornaviruses (D. A. Baker, Master's thesis, Univ of Rochester, New York). Stock preparations of RMV were obtained by injecting suckling mice intracerebrally with the virus. Then, at the height of the disease, brains were removed, and a 10% homogenate was prepared in MEM and stored at -70C until used. The pool had a titer of I X 107 PFU/ml in secondary mouse embryo fibroblast cell cultures.
Interferon assay. Confluent L-cell monolayers grown in 35-mm plastic petri dishes (Falcon Plastics, Los Angeles, Calif.) were treated with 1 ml of the appropriate interferon dilution overnight at 37 C. The plaque reduction assay used VSV as the challenge virus and has been previously described (9) . An internal, laboratory reference interferon standard was included with each assay, and the sensitivity of our assay was compared with the International Standard obtained from NIH. In our system, the International Standard had a titer of approximately 350 units/ml in comparison with its accepted titer of 500 units/ml.
RESULTS
To determine the effect of EMC virus infection on the ability of mice to produce interferon in response to inducing agents, 6-to 7-week-old female CD-1 mice were injected by the intraperitoneal route with a 100%, lethal inoculum of EMC virus (ca. 2 x 103 PFU). Then, either 24, 48, 72, 96, or 120 hr after infection, groups of uninfected and infected mice (six mice per group) received a single injection of either poly I:C, Tilorone hydrochloride, NDV, or a strain of EMC virus (RMV) which is a potent interferon inducer. After injection of inducer, blood was drawn by cardiac puncture at a time when interferon levels were anticipated to be at a maximum, as determined by previous experiments. Blood samples were pooled by group, and serum was then collected and stored at -20 C until assayed for interferon.
Results from three experiments with each inducer are summarized in Fig. 1 (Fig. la) . At this time, EMCinfected mice produced only 2,800 units of interferon per ml of serum compared with 6,000 units,'ml in controls (a 53% reduction). As the infection progressed, EMC-infected mice developed an increasing degree of hyporesponsiveness to induction with RMV. By the time infection had progressed for 96 ar'.d 120 hr, the interferon response was decreased by 93 to 95%0 (130 and 190 units/ml of serum).
In control animals, NDV induced a mean serum interferon titer of 3,500 units/ml 6 hr after inoculation. The interferon levels induced in infected mice, following the injection of NDV 24 hr after infection with EMC virus, were actually higher than levels induced in uninfected control animals (Fig. lb) . The range of the three experiments was 100 to 225%7, of control interferon levels with a mean of 170% (6,500 units/ml of serum). This enhancement, however, was a transient phenomenon and, by 48 hr, the ability of infected mice to respond to induction by NDV had decreased, as evidenced by a 60% reduction in their capacity to produce interferon. By 96 and 120 hr after inoculation of EMC virus, a striking degree of hyporeactivity was observed with infected animals able to produce interferon levels in the serum which were only 19 to 21 % of control titers (700 to 970 units/ml of serum).
The interferon response induced by two synthetic, nonviral inducers (poly I:C and Tilorone hydrochloride) in both infected and uninfected animals was also determined. Poly I :C was injected by the intraperitoneal route at a concentration of 100 Ag/mouse, and animals were bled 4 hr later. Tilorone hydrochloride was diluted in PBS and administered orally by gastric intubation at a concentration of 250 mg/kg of body weight; mice were bled 18 hr later. A similar pattern of interferon response was observed in EMC-infected animals induced by either poly I:C or NDV. The data presented in Fig. 2a demonstrate that, 24 hr after EMC infection, the interferon levels induced by poly I:C in infected mice were consistently higher than those induced in uninfected control animals. The mean enhancement in three experiments was 170% (7,500 units/ml compared with 4,400) with a range of 135 to 230%. However, by 48 hr after infection, suppression of the interferon response had developed with serum levels of 2,600 units/ml being induced in EMC-infected mice compared with 6,400 units/ml in uninfected controls (a 59% reduction). of the levels observed in noninfected controls (1,500 and 630 units/ml, respectively). The development of hyporeactivity was most significant in EMC-infected animals stimulated with Tilorone. The results of this series of experiments are summarized in Fig. 2b . As early as 24 hr after infection, mice were capable of producing only 20% of control interferon levels (3,300 units/ml compared with 15,000 units/ml). This hyporeactive state persisted throughout the entire infection, with extremely low levels being induced when Tilorone was administered either 48 (820 units/ml, or 7%-of control levels), 72 (800 units/ml, or 9%, of control levels), or 96 (610 units/ml, or 8% of control levels) hr after EMC infection.
To determine if the reduction in serum interferon levels reflected a delay in interferon response rather than suppression, multiple serum samples were obtained at varying time periods after injection of either poly I:C, Tilorone hydrochloride, NDV, or RMV, which were given 96 hr after EMC virus infection. The timing of sample collection was dependent upon the inducer, and the results obtained are presented in Table 1 . In all cases, at each time period, maximum interferon levels were suppressed, documenting that the alteration of interferon levels observed in these experiments is representative of the effect of infection on the total interferon response.
DISCUSSION
The development of a state of hyporesponsiveness after a single injection or repeated injections of interferon inducers is a recognized phenomenon (1, 3, 6, (13) (14) (15) (16) 
